Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$2.59 USD
+0.04 (1.57%)
Updated May 15, 2024 02:09 PM ET
2-Buy of 5 2
A Value C Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Ayr Wellness Inc. [AYRWF]
Reports for Purchase
Showing records 61 - 80 ( 90 total )
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Assessing 2Q22 Cannabis Earnings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
2Q22 In-line, NJ & MA Adult-Use Ramp Drives 2H22, Outlook Reset, PT $14
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Management Guidance Revised; Revenue & EBITDA Slightly Below Consensus Figures
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: 2Q22 Week II Earnings Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
U.S. Cannabis 2Q22 Preview: Macro Impacting NT, Legislative Progess Warming
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
1Q22 Margin Pressure, Key Licenses Reaffirms 2H22 Pickup, PT to $25
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
NJ Adult-Use Cannabis Update: New Recreational Stores Added to Begin Sales
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Regulatory Delays Unthawing, Too Cheap to Ignore, 1Q22 Preview
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Consumer - Cannabis Industry Update: New Jersey Approval To Launch Adult-Use
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
The Most Compelling Valuation in US Cannabis Now has Room for Upside Surprise, Returning Top Pick
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
4Q21 Beat, Lowers 2022 Guide to Reset Expected Soft 1H22, Lower PT - $30
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
4Q21 Preview, Top-Line Growth & Operations Set Up for Strong ''22 Ramp
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S